Phase I study of 9-nitro-20(S)-camptothecin in combination with cisplatin for patients with advanced malignancies.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Verschraegen, CF; Vincent, M; Abbruzzese, JL; Siegler, D; Kavanagh, JJ; Loyer, E; Kudelka, AP; Rubin, E

Published Date

  • 2000

Published In

Volume / Issue

  • 922 /

Start / End Page

  • 345 - 348

PubMed ID

  • 11193919

Pubmed Central ID

  • 11193919

International Standard Serial Number (ISSN)

  • 0077-8923

Digital Object Identifier (DOI)

  • 10.1111/j.1749-6632.2000.tb07061.x

Conference Location

  • United States